ArticleFrontiers in immunology2023

Case Report: Toripalimab: a novel immune checkpoint inhibitor in advanced nasopharyngeal carcinoma and severe immune-related colitis.

Canhua Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.